GE HealthCare (GEHC) reported fourth-quarter earnings that surpassed analyst expectations. The company posted earnings per share of $1.44, exceeding the consensus of $1.40. Revenue also came in strong at $5.7 million. This positive performance, driven by strength in the U.S. and European markets, has boosted investor confidence in the healthcare technology provider.

GE HealthCare's 2026 outlook is promising, forecasting adjusted earnings per share between $4.95 and $5.15, implying substantial year-over-year growth. The company expects organic revenue to increase between 3% and 4%. With adjusted EBIT margins projected to expand and a focus on profitable growth, GE HealthCare is positioning itself for continued success in a dynamic market.

This positive outlook follows GE HealthCare's third year as a public company, where the company has shown focus on precision care and growth acceleration. The company expects free cash flow to reach approximately $1.7 billion. Investors will be watching how GE HealthCare navigates the macro environment and delivers on its financial targets.

GE HealthCare's strong results come amid broader trends of increased investment in healthcare technology and innovation. The company's focus on a differentiated innovation pipeline and strategic cost management could help the company to maintain its momentum. Peter Arduini, GE HealthCare's CEO, is optimistic about the future.